跳至主要内容
临床试验/NCT04291235
NCT04291235Unknown不适用

The NEUROlogically-impaired Extubation Timing Trial

Sunnybrook Health Sciences Centre14 个研究点 分布在 1 个国家目标入组 332 人开始时间: 2020年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
332
试验地点
14
主要终点
Total Duration of Mechanical Ventilation

研究概览

简要总结

This trial in brain-injured patients will test which of the following will lead to better patient outcomes: (1) an airway management pathway consisting of daily assessments and removal of the breathing tube as soon as patients can breathe on their own and appear able to protect their airway; versus (2) the usual treatment patients would have received if they were not enrolled in this trial.

详细描述

Thousands of patients suffer severe brain injuries every year, from causes such as trauma, stroke, and infection. These patients are usually not fully awake and need help with their breathing and with preventing them from choking on their secretions. This is done with a breathing tube inserted through the mouth into the lungs and connected to a breathing machine. As patients recover, It is often unclear when the best time is to remove the breathing tube. Doctors might decide to remove it relatively early, or they may wait until the patient is more fully awake, or they may perform a tracheostomy (neck surgery to insert a new tube directly into the windpipe (trachea), replacing the temporary breathing tube). Each of these approaches has risks and benefits. This trial in brain-injured patients will test which of the following will lead to better patient outcomes: (1) an airway management pathway consisting of daily assessments and removal of the breathing tube as soon as patients can breathe on their own and appear able to protect their airway; versus (2) the usual treatment patients would have received if they were not enrolled in this trial.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age > 16 years
  • •Acute brain injury (subarachnoid hemorrhage, diffuse axonal injury, ischemic stroke, intracerebral hemorrhage, brain tumor, global cerebral anoxia/cardiac arrest, meningitis/encephalitis, cerebral abscess, epidural hematoma, subdural hematoma, seizure) that occurred within the previous 4 weeks
  • •Receiving mechanical ventilation via endotracheal tube for ≥ 48 hours

排除标准

  • •Quadriplegic
  • •Neuromuscular disease that will result in prolong need for mechanical ventilation, including but not limited to Guillain-Barre syndrome, cervical spinal cord injury, advanced multiple sclerosis
  • •Do-Not-Reintubate order in place
  • •Previously randomized in this trial
  • •Underlying pre-existing condition with life expectancy less than 6-months
  • •Current enrolment in an RCT that precludes NEURO-ETT co-enrollment

研究组 & 干预措施

Airway Management Pathway

Active Comparator

An airway management pathway consisting of daily assessments and removal of the breathing tube as soon as patients can breathe on their own and appear able to protect their airway

干预措施: Airway Management Pathway (Procedure)

Usual Care

Active Comparator

The usual clinical practice is often to keep the patient on artificial respiration for longer in the hope that the patient will wake up before removing the tube, or performing a tracheostomy if the patient doesn't wake up

干预措施: Usual Care (Procedure)

结局指标

主要结局

Total Duration of Mechanical Ventilation

时间窗: Up to 60 Days

Total duration of mechanical ventilation (to 60 days) accounting for the competing risk of death

次要结局

  • Mortality at ICU discharge and Hospital Discharge(ICU Discharge, Hospital Discharge, 3 months, and 6 months)
  • ICU Free Days At Day 60(Up to 60 Days)
  • Antibiotics Days(Up to 30 Days)
  • Nutrition Intake(Up to 6 Months)
  • Tracheostomy Rates(Up to 6 Months)
  • Delirium Free Days(Up to 30 Days)
  • Ventilator-Free Days at Day 60(Up to 60 days)
  • Airway or Tracheostomy complications(Up to 30 days)
  • Discharge Destination(Hospital discharge, up to 90 days)
  • ICU Readmission Rates(Hospital discharge, up to 90 days)
  • Extended Glasgow Outcome Score(3 months and 6 months)
  • EuroQol-5D(3 months and 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Damon Scales

Chief of Critical Care Medicine

Sunnybrook Health Sciences Centre

研究点 (14)

Loading locations...

相似试验